For the MYC + DLBCL subgroup, 13 patients were PET-positive at both I-PET and EoT-PET, whereas for the MYC- DLBCL patients, 16 were PET-positive at both I-PET and EoT-PET. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.